Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sleep Wake Disorders × exemestane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 186 Neoplasm Metastasis 19 Neoplasms 6 Breast Neoplasms, Male 6 Ovarian Neoplasms 4 Breast Diseases 4 Obesity 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Carcinoma In Situ 3 Breast Cancer Metastatic 3 Recurrence 2 Prostatic Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bulbo-Spinal Atrophy, X-Linked 2 Arthralgia 2 Advanced Breast Cancer 2 Vitamin D Deficiency 1 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Wake Disorders 1 Skin Diseases 1 Sexuality 1 Primary Breast Cancer ER+ve 1 Premenopausal Breast Cancer 1 Post Menopausal Women With Early Breast Cancer 1

Interventions

Therapeutics 4 Yoga 2 Tamoxifen 2 Psychiatric Rehabilitation 2 Methylphenidate 2 Melatonin 2 Educational Status 2 Early Intervention, Educational 2 Counseling 2 Cognitive Behavioral Therapy 2 Behavior Therapy 2 exemestane 1 Zolpidem 1 Venlafaxine Hydrochloride 1 Valeriana extract 1 Uncertainty 1 Ultraviolet Therapy 1 Triptorelin Pamoate 1 Surveys and Questionnaires 1 Saline Solution 1 Psychosocial Intervention 1 Phototherapy 1 N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide 1 Modafinil 1 Methods 1 Methadone 1 Metformin 1 Hypnosis 1 Gonadotropin-Releasing Hormone 1 Exercise Test 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00659373 2016-07-25

Co-SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed

86 enrolled 4 charts

Breast Neoplasms, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡